CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 246 filers reported holding CORCEPT THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $406,997 | +36.1% | 18,292 | +56.6% | 0.06% | +39.5% |
| Q3 2022 | $299,000 | +48.8% | 11,677 | +15.3% | 0.04% | +258.3% |
| Q4 2021 | $201,000 | -86.2% | 10,128 | -87.9% | 0.01% | -93.5% |
| Q3 2020 | $1,455,000 | -38.6% | 83,599 | -40.6% | 0.19% | -38.8% |
| Q2 2020 | $2,369,000 | +1061.3% | 140,819 | +722.7% | 0.30% | +1025.9% |
| Q1 2020 | $204,000 | – | 17,116 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 6,825,262 | $138,621 | 7.54% |
| Novo Holdings A/S | 3,377,768 | $68,602,468 | 4.28% |
| Parallel Advisors, LLC | 3,724,664 | $75,647,926 | 3.28% |
| TANAKA CAPITAL MANAGEMENT INC | 35,539 | $722 | 2.29% |
| Quantedge Capital Pte Ltd | 251,312 | $5,104,147 | 1.71% |
| S&T BANK/PA | 346,306 | $7,033 | 1.30% |
| Freshford Capital Management, LLC | 249,000 | $5,057,190 | 1.09% |
| Birchview Capital, LP | 50,000 | $1,016 | 0.72% |
| FAS Wealth Partners, Inc. | 306,276 | $6,220,466 | 0.70% |
| Bridge City Capital, LLC | 60,824 | $1,235 | 0.63% |